Back

Gene therapy: the future of personalised atrial fibrillation management?

18 June 2017 (15:07 - 15:30)
Organised by:
Congress Presentation Part of: Gene and molecular therapies for cardiac arrhythmias and SCD Molecular biology / genetics EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Associate Professor Dierk Thomas

University Hospital Heidelberg, Heidelberg (Germany)

3 More presentations in this session

Presentation thumbnail
Gene therapy calcium handling dysfunction in heart failure.
Professor O. Mueller (Kiel, DE)
Presentation thumbnail
Gene therapy of inherited arrhythmias.
Doctor C. Napolitano (Pavia, IT)
Slides Video
Presentation thumbnail
Molecular strategies to treat post MI arrhythmias.
Professor L. Gepstein (Haifa, IL)

Access the full session

Session thumbnail
Gene and molecular therapies for cardiac arrhythmias and SCD

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 15:07 CET
You may be interested in
thumbnail
Congress Session
Epicardial/endocardial hybrid treatments: combining strengths, restoring rhythm
30 March 2025
thumbnail
Congress Presentation
Association between personalized evidence-based anticoagulation therapy and outcomes at 1-year follow-up in patients with atrial fibrillation: an analysis from the Atrial Fibrillation Registry
29 June 2021
thumbnail
Congress Presentation
Genetic aspects associated with increased risk of developing atrial fibrillation
15 June 2024
thumbnail
Congress Presentation
Wearable-based shock-free control of cardiac rhythm for acute ambulatory cardioversion of atrial fibrillation
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources